Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SUVARNA NOMULA

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1801972070
CMS profile
353871
Location
TAMPA, FL

General Payments · PY2018–2024

$6,395.29

  • Reported across 439 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$563.65

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $563.65 37

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $169.06 15
Lilly USA, LLC $83.46 5
Acerta Pharma LLC $72.37 4
PFIZER INC. $60.17 3
Boehringer Ingelheim Pharmaceuticals, Inc. $57.07 3
GlaxoSmithKline, LLC. $50.42 3
SANOFI-AVENTIS U.S. LLC $35.81 2
Amgen Inc. $18.59 1
Abbott Laboratories $16.70 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,326.84 89
PY2019 $1,234.13 86
PY2020 $947.56 79
PY2021 $645.12 55
PY2022 $796.49 36
PY2023 $881.50 57
PY2024 $563.65 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $16.70 09/18/2024 Food and Beverage Undisputed 01/23/2026 1125282610 CMS
Amgen Inc. $18.59 05/29/2024 Food and Beverage Undisputed 01/23/2026 1117642587 CMS
AstraZeneca Pharmaceuticals LP $19.41 01/24/2024 Food and Beverage Undisputed 01/23/2026 1104730509 CMS
AstraZeneca Pharmaceuticals LP $17.25 04/16/2024 Food and Beverage Undisputed 01/23/2026 1105545355 CMS
AstraZeneca Pharmaceuticals LP $17.93 05/14/2024 Food and Beverage Undisputed 01/23/2026 1105766932 CMS
AstraZeneca Pharmaceuticals LP $17.78 10/16/2024 Food and Beverage Undisputed 01/23/2026 1104244657 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.40 01/10/2024 Food and Beverage Undisputed 01/23/2026 1118162338 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.51 03/27/2024 Food and Beverage Undisputed 01/23/2026 1118162334 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.16 11/26/2024 Food and Beverage Undisputed 01/23/2026 1118162336 CMS
GlaxoSmithKline, LLC. $17.98 04/03/2024 Food and Beverage Undisputed 01/23/2026 1116409109 CMS
GlaxoSmithKline, LLC. $16.21 06/17/2024 Food and Beverage Undisputed 01/23/2026 1116523676 CMS
GlaxoSmithKline, LLC. $16.23 10/24/2024 Food and Beverage Undisputed 01/23/2026 1116601471 CMS
Lilly USA, LLC $15.45 04/09/2024 Food and Beverage Undisputed 01/23/2026 1135470687 CMS
Lilly USA, LLC $14.47 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135434789 CMS
Lilly USA, LLC $18.15 09/18/2024 Food and Beverage Undisputed 01/23/2026 1135425931 CMS
Lilly USA, LLC $16.64 09/27/2024 Food and Beverage Undisputed 01/23/2026 1135398483 CMS
Lilly USA, LLC $18.75 11/13/2024 Food and Beverage Undisputed 01/23/2026 1135398485 CMS
Novo Nordisk Inc $9.65 01/31/2024 Food and Beverage Undisputed 01/23/2026 1096642374 CMS
Novo Nordisk Inc $18.37 03/04/2024 Food and Beverage Undisputed 01/23/2026 1096835552 CMS
Novo Nordisk Inc $7.69 03/07/2024 Food and Beverage Undisputed 01/23/2026 1097663675 CMS
Novo Nordisk Inc $15.39 04/11/2024 Food and Beverage Undisputed 01/23/2026 1097521949 CMS
Novo Nordisk Inc $5.87 04/23/2024 Food and Beverage Undisputed 01/23/2026 1097624821 CMS
Novo Nordisk Inc $19.87 06/03/2024 Food and Beverage Undisputed 01/23/2026 1096649825 CMS
Novo Nordisk Inc $19.68 07/10/2024 Food and Beverage Undisputed 01/23/2026 1096932961 CMS
Novo Nordisk Inc $19.50 08/06/2024 Food and Beverage Undisputed 01/23/2026 1097737731 CMS
Novo Nordisk Inc $8.95 08/15/2024 Food and Beverage Undisputed 01/23/2026 1096588577 CMS
Novo Nordisk Inc $8.47 08/19/2024 Food and Beverage Undisputed 01/23/2026 1097799729 CMS
Novo Nordisk Inc $5.72 09/19/2024 Food and Beverage Undisputed 01/23/2026 1096900579 CMS
Novo Nordisk Inc $10.20 10/18/2024 Food and Beverage Undisputed 01/23/2026 1096953289 CMS
Novo Nordisk Inc $5.17 10/19/2024 Food and Beverage Undisputed 01/23/2026 1097587322 CMS
Novo Nordisk Inc $6.89 11/14/2024 Food and Beverage Undisputed 01/23/2026 1097554533 CMS
Novo Nordisk Inc $7.64 12/05/2024 Food and Beverage Undisputed 01/23/2026 1097649751 CMS
PFIZER INC. $26.03 01/09/2024 Food and Beverage Undisputed 01/23/2026 1130985558 CMS
PFIZER INC. $15.76 09/25/2024 Food and Beverage Undisputed 01/23/2026 1132032637 CMS
PFIZER INC. $18.38 11/20/2024 Food and Beverage Undisputed 01/23/2026 1132112831 CMS
SANOFI-AVENTIS U.S. LLC $15.17 04/02/2024 Food and Beverage Undisputed 01/23/2026 1139732424 CMS
SANOFI-AVENTIS U.S. LLC $20.64 11/05/2024 Food and Beverage Undisputed 01/23/2026 1139732494 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.